News about Market

Indegene Named Leader in Life Sciences AI and Analytics by Everest Group

Global research and consulting firm Everest Group has named Indegene a Leader in its Life Sciences AI and Analytics Services” for Commercial PEAK Matrix Assessment 2025.

Market | 31/07/2025 | By Dineshwori |  290

Strides Pharma Q1 FY26 PAT Soars 81% YoY; EBITDA Margin Expands to 19.5%

Strides Pharma Science Ltd has reported a robust financial performance for the first quarter of FY26, with consolidated revenue reaching INR 1,119.7 crore — a 6.2 percent increase from INR 1,053.9 crore recorded in the same quarter of the previous fiscal year.

Market | 30/07/2025 | By Darshana |  259

Jubilant Pharmova Q1 FY26 Net Profit Rises 48% to INR 60 Crore, CDMO and Specialty Pharma Drive Growth

Jubilant Pharmova Ltd reported a strong performance for the first quarter of FY26, with its consolidated net profit rising 48% year-on-year to INR 60 crore, up from INR 41 crore in Q1 FY25. Total revenue for the quarter grew 10% to INR 1,650 crore, compared to INR 1,500 crore in the corresponding period last year.

Market | 30/07/2025 | By Darshana |  573

Torrent Pharma Posts INR 3,178 Cr Revenue in Q1 FY26, Net Profit Up 20% on Strong Domestic Growth

Torrent Pharmaceuticals reported a revenue of INR 3,178 crore for the first quarter of FY26, marking a 10% increase compared to the same period last year. The company also posted a 20% year-on-year rise in net profit, which stood at INR 449 crore for the quarter.

Market | 29/07/2025 | By Darshana |  223

India's Pharma Sector Shows Strategic Maturity Amid Global Tariff Shocks: Rubix Report

In this dynamic environment, Rubix Data Sciences, a leading provider of risk management and compliance monitoring solutions, has released a comprehensive industry report that captures how Indian pharmaceutical companies are navigating volatility by focusing on complex generics, regulatory strength, and global expansion.

Market | 24/07/2025 | By Darshana |  276

Kilitch Drugs to Raise INR 49.92 Cr via Rights Issue to Fund Greenfield Expansion and Growth Plans

At its recent board meeting, the company approved the issuance of 1,398,463 fully paid-up equity shares at INR 357 per share (face value INR 10 and premium of INR 347). The entitlement ratio for eligible shareholders is 2 rights equity shares for every 23 fully paid equity shares held.

Market | 24/07/2025 | By Darshana |  368

Syngene Reports 14.5% YoY Growth in Q1 Net Profit, Driven by Strong Research Services Momentum

Operational revenue grew by 10.7% to INR 874.5 crore from INR 789.7 crore in Q1 FY25. EBITDA for the quarter rose 19% to INR 224 crore, compared to INR 188 crore last year. The EBITDA margin improved to 25%, up from 23% a year ago.

Market | 24/07/2025 | By Darshana |  369

DGFT Extends Deadline for Pharma-Grade Sugar Export Quota Applications to July 31

Exporters must apply online via DGFT’s e-Commerce portal under the “Non-SCOMET Restricted Items” category. Previously, applications were to be submitted between June 20 and July 20, 2025.

Market | 23/07/2025 | By Darshana |  311

Torrent Pharma Seeks CCI Nod for INR 19,500 Crore Acquisition of JB Chemicals

According to the filing, the transaction involves acquisition of shares in JB Chemicals, followed by the amalgamation of the target company with Torrent Pharmaceuticals.

Market | 18/07/2025 | By Darshana |  566

Novartis Reports Double-Digit Sales Growth In Q2, Raises Full-Year Guidance

Novartis has reported a robust financial performance for the second quarter of 2025, with net sales reaching USD 14.1 billion, up 12 percent year-on-year.

Market | 17/07/2025 | By Dineshwori |  1378